Practising Law Institute: Health Care 2010: Managing Risks in the New Compliance and Enforcement Environment
New York, New York
This conference, presented by PLI, will focus on the recent changes in health care law, including those that will come about as a result of the recently passed health care reform bill. Attendees will have the opportunity to hear speakers from the FDA, FTC, DOJ, OMIG, as well as in-house and outside counsel, discuss the new reform bill andrecent enforcement initiatives, including the focus on FCPA violations by pharmaceuticals, the creation of HEAT and prosecutions of executives under the FDCA. Topics to be discussed include: structuring compliant relationships with health care providers and clinical investigators; scientific discourse and promotional guidelines affecting FDA-regulated products; federal and state compliance and investigation issues, including issues arising under disclosure, false claims, anti-kickback, and Stark laws; ethical issues in advising clients in the health care industry; and health care reform developments affecting your client.
WilmerHale partner David Ogden will be a featured speaker at this event. He will speak on the topic of "Health Care Reform: Impact on Compliance and Enforcement Initiatives."
A global team handling highly complex and sensitive matters in all aspects of litigation
Drawing on years of experience in the public and private sectors, our lawyers handle a range of litigation involving the federal government, state and foreign governments, and complex regulatory regimes.
WilmerHale offers one of the world’s premier international arbitration and dispute resolution practices.
Bringing significant depth and critical experience to government contracting matters
Advising clients on changing priorities, new regulations, emerging threats and untapped opportunities.
Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.